Sirio Pharma
17758 Rowland St.
City of Industry, CA 91748
Phone: (626) 912-9998
Founded in 1993, Sirio Pharma Co., Ltd (SIRIO) is the leading global nutraceutical CDMO specialized in developing and manufacturing quality products including gummies, soft gels, capsules, tablets, powders, functional beverages, probiotics and other dosage forms. The company has extensive capabilities with multiple manufacturing sites in Germany, USA and China. SIRIO offers end-to-end service with solutions including product development, manufacturing, packaging and logistics to its customers.
Sara Lesina has more than 20 years of experience in the B2B and B2C space, with a proven track record of delivering leveraged growth, competitive advantage and customer excellence across the health, wellness, food and pharma industries. She has held various roles in marketing, product management, business development, sales and general management, and has worked for companies such as Cargill, Capsugel/Lonza, and now, Sirio. She has a master’s degree in marketing from the University of Torino, Italy, and the University of Helsinki, Finland, and an Executive MBA from Vlerick Business School, Belgium. As the general manager of Sirio Europe and Americas, Lesina leads a dynamic and diverse organization that provides contract development and manufacturing services for the pharmaceutical and nutraceutical industries.
NIE: Sirio will launch a personalized women’s health platform at Vitafoods Europe. Talk about the range and why the company decided to launch it.
Lesina: Our women’s health platform provides a diverse array of nutritional supplements designed to target women’s specific health needs through all life stages, such as hormonal balance, reproductive health, bone health, skin vitality and overall well-being. The decision to introduce this platform stems from the rising demand for personalized health solutions and our pledge to adapt to changing consumer preferences. Through extensive research and development efforts, we’ve developed scientifically supported products to empower women in taking proactive steps towards their health. This launch underscores our ongoing commitment to innovation and our mission to promote women’s health globally.
NIE: What steps does Sirio take to ensure quality control?
Lesina: Sirio Pharma Co., Ltd. is committed to unwavering quality assurance, integrating rigorous testing protocols into our manufacturing processes. With five cutting-edge research and development facilities spanning the globe, we leverage high-precision testing equipment to ensure the integrity and potency of our products. Our commitment to quality is underscored by our acquisition of over 32 global certifications, reflecting our dedication to meeting and exceeding industry standards. Moreover, we guarantee 100 percent traceability of ingredients, enabling us to track each component from its source to the finished product. This meticulous approach to quality control empowers Sirio to deliver nutritional supplements of unparalleled safety and efficacy to customers worldwide.
NIE: The company recently collaborated with Cargill and introduced BloomDays Postbiotic Gummies. What is in the formula and what are the benefits?
Lesina: The BloomDays Postbiotic Gummies, a collaborative effort between Sirio Pharma Co., Ltd. and Cargill, feature Cargill’s EpiCor postbiotic ingredient. This unique ingredient is derived from whole food yeast fermentate and is backed by extensive scientific research, including eight human and eight pre-clinical studies. The formula contains 500 mg of EpiCor per two-gummy serving, targeting immune health and promoting a healthy gut microbiome. These plant-based gummies are sugar-free and contain only natural flavors and sweeteners, aligning with consumer preferences for health-conscious and sustainable choices. With Sirio’s deep roots in health and wellness product development and Cargill’s high-quality postbiotic ingredient, BloomDays offers consumers a delicious and effective way to support their immune and gut health.
NIE: Sirio has more than 30 years of experience under its belt. What are some of the company’s goals for the future?
Lesina: Sirio Pharma Co is dedicated to maintaining its position as a leader in the global market for nutritional supplements. Looking ahead, the company has set several ambitious goals. First, Sirio aims to expand its product portfolio by introducing new and more innovative nutritional supplements that cater to emerging consumer trends and evolving health needs. Additionally, the company seeks to further penetrate global markets, leveraging its established presence in key regions while tapping into new territories with growing demand for health and wellness products. Research and development remain a priority for Sirio, with a focus on scientific breakthroughs to enhance product formulations and develop novel ingredients and delivery systems.
Sustainability initiatives are also on the agenda, as Sirio is committed to reducing its environmental footprint through more eco-friendly manufacturing practices, packaging innovations and ethically sourced ingredients. Moreover, strategic partnerships and collaborations with industry stakeholders are integral to Sirio’s growth strategy, as is maintaining a strong focus on customer satisfaction and quality assurance. Finally, the company remains committed to corporate social responsibility, aiming to positively impact the communities it serves through various initiatives.
